Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Potent antitumor farnesyltransferase inhibitors discovered by Parke-Davis

April 29, 1997

SKB describes potent, selective IL-8beta receptor antagonists

April 29, 1997

Potent and selective iNOS inhibitor disclosed by Merck & Co.

April 29, 1997

DuPont Merck describes potent, orally bioavailable cyclic urea HIV protease inhibitor

April 29, 1997

PD-170262: potent and selective PDGF TK inhibitor from Parke-Davis

April 29, 1997

Pharmacia & Upjohn prepares potent and selective dopamine D4 antagonist

April 29, 1997

Pharmacokinetic data for pentafuside in rodents, monkeys and man

April 29, 1997

RPR describes novel farnesyltransferase inhibitors

April 28, 1997

Parke-Davis SAR studies lead to potent, selective D4 antagonist

April 28, 1997

Potent TNF inhibitor described by Celgene

April 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....